Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:
- Aromatase Inhibitors
- Aromatase Inhibitors & Breast Cancer

Aromatase Inhibitors Newsletter

Biopharmaceutical Research Company (BRC) Announces Development and Regulatory Milestone Following Successful Type C CMC Meeting with FDA, Advancing Clinical Development of Multiple Therapeutic Candidates 29 Jan 2025 16:11 GMT
… Regional Pain Syndrome (CRPS) and Aromatase Inhibitor Induced Arthralgia (AIIA), respectively. …
Sermonix Announces Clinical Breast Cancer Publication of Article Examining Effects of Lasofoxifene Versus Fulvestrant on Urogenital Symptoms in Patients with ESR1-Mutated ER+/HER2- Metastatic Breast Cancer 29 Jan 2025 15:19 GMT
… breast cancer who previously had aromatase inhibitor-CDK4/6is, 52 women …
Metronomic Capecitabine With an Aromatase Inhibitor Demonstrates Safety, Efficacy in Treatment of HR+, HER2– Metastatic Breast Cancer 15 Jan 2025 17:58 GMT
… (Xeloda; Genetech) plus an aromatase inhibitor in the first line demonstrated … capecitabine in combination with an aromatase inhibitor. Their study involved 263 … metronomic capecitabine plus an aromatase inhibitor or an aromatase inhibitor alone. The primary …
Inavolisib Combo Meets OS End Point in PIK3CA+ Metastatic Breast Cancer 28 Jan 2025 23:28 GMT
… only (47.7%), aromatase inhibitor only (40.3%), and aromatase inhibitor and tamoxifen (11 …
Balancing Innovation and Equity in Oncology Value-Based Care: Panel Discussions 28 Jan 2025 23:22 GMT
… pair the treatment with an aromatase inhibitor effectively, she explained. Regarding the …
Hydroxychloroquine Enhances the Efficacy of Palbociclib, Letrozole Therapy in Patients With HR+, HER2– Metastatic Breast Cancer 28 Jan 2025 22:54 GMT
… inhibitor plus ET with an aromatase inhibitor as standard of care.1 …
EC Approves Ribociclib/Aromatase Inhibitor For HR+/HER2– Early Breast Cancer 02 Dec 2024 19:20 GMT
… for 36 months. The nonsteroidal aromatase inhibitor was either anastrozole (Arimidex) at … with tamoxifen, raloxifene, or aromatase inhibitors for reduction in risk of … al. Adjuvant ribociclib plus nonsteroidal aromatase inhibitor in patients with HR+…
Aromatase Inhibitor Therapy May Not Affect CV Disease Risk 05 Nov 2024 13:24 GMT
… cancer (BC) includes tamoxifen and aromatase inhibitors (AIs); however, the use of …
2024 Research: Global Invasive Ductal Carcinoma Treatment Market Set To Reach $23.02 Billion By 2034, - Rising Prevalence Of Breast Cancer Fuels Advancements In Personalized Medicine 27 Jan 2025 10:11 GMT
… existing therapies like tamoxifen and aromatase inhibitors proving effective for these cancer …
The quality of life under an aromatase inhibitor is very poor 17 Oct 2024 06:56 GMT
… . I have been on an aromatase inhibitor for the past eight months … cancer and its treatment — an aromatase inhibitor (AI). Aromatase is the enzyme …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS